Magenta Therapeutics (NASDAQ:MGTA) reported quarterly losses of $(0.29) per share. This is a 9.38 percent increase over losses of $(0.32) per share from the same period last year.
Related Posts
EXCLUSIVE: BioRestorative Completes Dosing In Safety Cohort Of Chronic Lower Back Pain Trial
BioRestorative Therapies Inc (NASDAQ: BRTX) announced that the final subject in its BRTX-100 Phase 2 trial safety cohort has been dosed.
Why These 5 Tesla Analysts Have Mixed Views On Q3: ‘We Were Prepared For An Earnings Miss’
Tesla Inc (NASDAQ: TSLA) reported record revenue, operating margins and free cash flow in the third quarter.
Constellation Brands Q2 EPS $3.17 Beats $2.81 Estimate, Sales $2.65B Beat $2.51B Estimate
Constellation Brands (NYSE:STZ) reported quarterly earnings of $3.17 per share which beat the analyst consensus estimate of $2.81 by 12.81 percent. This is a 33.19 percent increase over earnings of $2.38 per share from